Efficacy and safety of cladribine addition to induction treatment of newly diagnosed acute myeloid leukemia: a systematic review and meta-analysis.

Published in: Hematology (Amsterdam, Netherlands) (2021)

This meta-analysis suggests that cladribine-containing regimens are likely to be effective and safe for induction treatment of newly diagnosed AML patients. However, large sample size and prospective controlled studies are needed to confirm our findings.

Keyphrases

newly diagnosed
acute myeloid leukemia
systematic review
end stage renal disease
ejection fraction
case control
combination therapy
peritoneal dialysis
patient reported outcomes